SCIE期刊HUMAN GENE THERAPY 2024/2025影響因子:3.988 (HUM GENE THER) (1043-0342). (GENETICS & HEREDITY)(遺傳學(xué)和遺傳)Science Citation

切口

SCIE(SCI)期刊HUMAN GENE THERAPY(20 21 REV HIST)影響因子


SCIE(SCI)期刊HUMAN GENE THERAPY(HUM GENE THER)影響因子@(遺傳學(xué)和遺傳)學(xué)科排名


SCIE(SCI)期刊HUMAN GENE THERAPY(20 21 REV HIST)總引論文


SCIE(SCI)期刊HUMAN GENE THERAPY(HUM GENE THER)總引論文@(遺傳學(xué)和遺傳)學(xué)科排名


SCIE(SCI)期刊HUMAN GENE THERAPY(20 21 REV HIST)影響因子


SCIE(SCI)期刊HUMAN GENE THERAPY(HUM GENE THER)總引頻次@(遺傳學(xué)和遺傳)學(xué)科排名


SCIE(SCI)期刊HUMAN GENE THERAPY(20 21 REV HIST)即時影響因子


SCIE(SCI)期刊HUMAN GENE THERAPY(HUM GENE THER)即時影響因子@(遺傳學(xué)和遺傳)學(xué)科排名


SCIE(SCI)期刊HUMAN GENE THERAPY(20 21 REV HIST)五年累積影響因子


SCIE(SCI)期刊HUMAN GENE THERAPY(HUM GENE THER)五年累積影響因子@(遺傳學(xué)和遺傳)學(xué)科排名

稱贊

不可救藥

過分自信

敬禮

Submitted on: 11 July 2022. Revised on: 02 August 2022. Accepted on: 26 August 2022. ___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

propose

Submitted on: 07 September 2003. Revised on: 24 October 2003. Accepted on: 13 December 2003. ___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

Angioplasty

ELATE

Submitted on: 15 January 2003. Revised on: 17 April 2003. Accepted on: 30 May 2003. ___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

半導(dǎo)體

Submitted on: 27 September 2021. Revised on: 30 December 2021. Accepted on: 20 January 2022. ___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

少量